Related Experiment Video

Updated: Apr 27, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

[Allogeneic stem cell transplantation from an HLA-haploidentical related donor: SFGM-TC recommendations (Part 1)]

D Blaise1, S Nguyen2, J-O Bay3

  • 1Unité de transplantation médullaire, institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, BP 156, 13273 Marseille, France.

Pathologie-Biologie
|June 30, 2014
PubMed

Insights

Haploidentical allogeneic stem cell transplantation is a growing alternative to other stem cell sources. Further research is needed to confirm its role in routine patient care, with ongoing efforts to standardize practices.

Area of Science:

  • Hematology
  • Immunology
  • Oncology

Context:

  • Haploidentical allogeneic stem cell transplantation (CST) has gained global traction over the last decade.
  • It is emerging as a viable alternative to other stem cell sources.
  • However, its integration into standard patient care requires further validation through research.

Purpose:

  • To harmonize clinical practices for haploidentical allogeneic stem cell transplantation across French centers.
  • To establish recommendations for allogeneic stem cell transplantation from HLA-haploidentical related donors.
  • To facilitate knowledge sharing and standardization among practitioners.

Summary:

  • The French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC) convened its fourth annual workshop in Lille, September 2013.
  • Practitioners from SFGM-TC member centers convened to discuss and harmonize practices.
  • This document presents part one of the recommendations for allogeneic stem cell transplantation using HLA-haploidentical related donors.

Impact:

  • Aims to standardize and improve the quality of care for patients undergoing haploidentical stem cell transplantation.
  • Provides a foundation for future research and clinical guidelines in the field.
  • Facilitates the broader adoption of a potentially life-saving treatment modality.

Keywords:
Allogeneic stem cell transplantationAllogreffe de cellules souches hématopoïétiquesAlternative graftsDonneur HLA-haploidentiqueGreffes alternativesHLA-haploidentical donor

More Related Videos

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

9.8K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

3.4K

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
3.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K